skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

Refine Results

Clear All

Specialism

もっと見る

Resources

もっと見る

Products

もっと見る

もっと見る

13 Total results for product and free and sample content found

Medtech Insight: 世界の医療機器・医療技術の最新情報

Boston Scientific Divests Specialty Pharma Business

By Reed Miller 08 Dec 2020

The $800m sale of BTG Specialty Pharmaceuticals business to SERB leaves Boston Scientific with BTG’s successful interventional oncology and vascular products.

Topic M A Market Intelligence

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Buyers and Sellers: How Corporate Transactions are Shaping the Big Pharma Landscape

27 Nov 2020

Buyers and Sellers: How Corporate Transactions are Shaping the Big Pharma Landscape

Scrip has been scrutinizing significant M&A deals in the pharma industry in light of companies’ 2019 financial results. We bring you insights into the impact of major acquisitions and divestments by Big Pharma, and consider what it means for the future. 

Topic M A

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Amid New M&A Rumors, Amarin CEO Focused On Vascepa Approval

By Andrew McConaghie 27 Nov 2020

Article

John Thero insists company is focused on approval and launch, as interest in European rights grow.

Topic Cardiovascular M A

Biomedtracker: 開発中医薬品をFDA承認確率で評価

A Historic Decade of Deal Making

27 Nov 2020

A Historic Decade of Deal Making

In preparation for the webinar, download your free infographic, a snapshot view of M&A’s biggest deals and major players and what their activities indicate for the year ahead.

Topic M A

Biomedtracker: 開発中医薬品をFDA承認確率で評価

A Decade of Biopharma Mergers and Acquisitions and Outlook for 2020 Whitepaper

By Daniel Chancellor 27 Nov 2020

A Decade of Biopharma Mergers and Acquisitions and Outlook for 2020 Whitepaper

Using M&A activity as a barometer for the overall health of the biopharma industry, we explore biopharma’s biggest deals of the past decade and examine what they may presage for the year to come. Dive into key insights on trends, M&A drivers, companies to watch, and more. 

Topic M A

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Quick Listen: Scrip's Five Must-Know Things

By Ian Haydock 17 Nov 2020

Scrip August Podcast

Take a brief audio tour around the main biopharma industry events of the past week, as brought to you by Scrip's global team, in this podcast version of Five Must-Know Things.

Topic Coronavirus M A

世界の薬事規制動向&情報を配信

Divided FTC Okays Mylan-Upjohn Merger But Election Outcome Could Impede Future Deals

By Brenda Sandburg 17 Nov 2020

mylan pfizer upjohn merger

Commissioners vote 3-2 that Mylan and Pfizer’s Upjohn can combine after divesting seven products; dissenting votes focus on price fixing allegations as commissioners Chopra and Slaughter criticize majority for not addressing government’s case against Pfizer and Mylan. Former FTC attorneys note that if Biden wins the presidential election, he could nominate one of the dissenters to FTC chair and give more traction to their views.

Topic US Election 2020 M A Legal Issues

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Quick Listen: Scrip's Five Must-Know Things

By Ian Haydock 28 Aug 2020

Scrip August Podcast

Join us for a quick audio roundup of five useful things to know from Scrip's recent coverage of the global biopharmaceutical sector. 

Topic Coronavirus M A

お問い合わせ&レポートストア

専任スタッフによるデモンストレーションを兼ねたサービスの詳しいご説明、または無料トライアルを常時受け付けています。ご希望の場合は下記のフォームよりお気軽にお申し込みください。

*一部のサービスでは無料トライアルをご利用になれません。


新型コロナウイルス感染拡大防止のため在宅勤務を実施しています。

お問合せの際はフォームまたは下記メールアドレスをご利用頂くか、営業担当者の携帯電話までご連絡下さいますようご協力をお願い申し上げます。

インフォーマインテリジェンス合同会社
ファーマインテリジェンス
Eメール:
inquiry.jp@informa.com

オンラインショップのレポートストアでは、医療用医薬品の市場調査・分析レポートを常時1000本以上販売しています。レポート1本単位で購入でき、オンラインでご提供いたします。

お探しの情報が見つからない場合はお問い合わせ先までお気軽にご連絡ください。